第1回
Point-of-Care Testing
-ポイントオブケア検査シンポジウム-
分子診断の実用化
2月19日〜20日

開発期間の短縮と経費の節減に伴って、臨床試験を効率化する必要性が高まるなか、患者を階層化するためにポイントオブケア検査を利用するケースが増えています。このシンポジウムでは、ポイントオブケア診断に対応する技術やトレンドを取り上げ、新薬開発分野における各種用途への適合性を検討するとともに、診断サービスのプロバイダーと製薬会社の両方にとってのビジネスチャンスを明らかにします。また、コンパニオン診断の導入まつわる問題やポイントオブケア検査が有効なツールであるとされる理由なども明らかにされることになっています。

Who Should Attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Large Pharma, Biotechs and Academia working in fields such as Diagnostics, Pathology, Infectious Diseases, R&D, Product Development, and Biotechnology.

Topics will include, but are not limited to:

• Technologies and trends in point-of-care diagnostics
• Deciding which companion diagnostic test to use
• Implementing companion diagnostics
• Partnering with a point-of-care diagnostic developer
• Deciding on criteria for selecting a POC device or provider
• Economics of the POC model for pharma
• Infrastructure needed to make POC work in pharma
• When in the drug development cycle is the right time to bring in a companion diagnostic?
• Who should own the test?
• Who should develop it?
• Can central labs obviate the need for POC in clinical trials?
• Which POC tests are ready for market?

The deadline for submission is July 29, 2011.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.